Springvloet, Linda
Triemstra, Mattanja
Knottnerus, Bart
Rolink, Marlon
Heijerman, Harry
de Boer, Dolf
Funding for this research was provided by:
Netherland-Davos Society
Article History
Received: 22 August 2022
Accepted: 6 December 2022
First Online: 13 January 2023
Declarations
:
: All patients provided their written informed consent on taking part in the clinical study which was approved by the Ethics Committee of the Academic Medical Center of the University of Amsterdam (Amsterdam, the Netherlands) [CitationRef removed]. The CaReQoL Asthma was not officially part of the clinical study, and an amendment about the additional informal data collection with this instrument was handed over to the Ethics Committee after the start of the clinical study.
: Not applicable.
: The authors declare that they have no competing interests.